Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25


UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.

Sarkissian CA, Alteri CJ, Mobley HLT.

Vaccine. 2019 Aug 14;37(35):4937-4946. doi: 10.1016/j.vaccine.2019.07.031. Epub 2019 Jul 15.


Flexible Metabolism and Suppression of Latent Enzymes Are Important for Escherichia coli Adaptation to Diverse Environments within the Host.

Alteri CJ, Himpsl SD, Shea AE, Mobley HLT.

J Bacteriol. 2019 Jul 24;201(16). pii: e00181-19. doi: 10.1128/JB.00181-19. Print 2019 Aug 15.


Can the Microbiome Deliver? A Proof-of-Concept Engineered E. coli PKU Therapeutic.

Alteri CJ.

Cell Host Microbe. 2019 Apr 10;25(4):473-474. doi: 10.1016/j.chom.2019.03.015.


Subtle variation within conserved effector operon gene products contributes to T6SS-mediated killing and immunity.

Alteri CJ, Himpsl SD, Zhu K, Hershey HL, Musili N, Miller JE, Mobley HLT.

PLoS Pathog. 2017 Nov 20;13(11):e1006729. doi: 10.1371/journal.ppat.1006729. eCollection 2017 Nov.


Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.

Eaton KA, Fontaine C, Friedman DI, Conti N, Alteri CJ.

Vet Pathol. 2017 Jul;54(4):710-719. doi: 10.1177/0300985817691582. Epub 2017 Feb 8.


The Versatile Type VI Secretion System.

Alteri CJ, Mobley HL.

Microbiol Spectr. 2016 Apr;4(2). doi: 10.1128/microbiolspec.VMBF-0026-2015. Review.


Development of a Vaccine against Escherichia coli Urinary Tract Infections.

Mobley HL, Alteri CJ.

Pathogens. 2015 Dec 31;5(1). pii: E1. doi: 10.3390/pathogens5010001.


Metabolism and Fitness of Urinary Tract Pathogens.

Alteri CJ, Mobley HLT.

Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0016-2015.


Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection.

Alteri CJ, Himpsl SD, Mobley HL.

PLoS Pathog. 2015 Jan 8;11(1):e1004601. doi: 10.1371/journal.ppat.1004601. eCollection 2015 Jan.


Arginine promotes Proteus mirabilis motility and fitness by contributing to conservation of the proton gradient and proton motive force.

Armbruster CE, Hodges SA, Smith SN, Alteri CJ, Mobley HL.

Microbiologyopen. 2014 Oct;3(5):630-41. doi: 10.1002/mbo3.194. Epub 2014 Aug 7.


PafR, a novel transcription regulator, is important for pathogenesis in uropathogenic Escherichia coli.

Baum M, Watad M, Smith SN, Alteri CJ, Gordon N, Rosenshine I, Mobley HL, Amster-Choder O.

Infect Immun. 2014 Oct;82(10):4241-52. doi: 10.1128/IAI.00086-14. Epub 2014 Jul 28.


SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains.

Nesta B, Valeri M, Spagnuolo A, Rosini R, Mora M, Donato P, Alteri CJ, Del Vecchio M, Buccato S, Pezzicoli A, Bertoldi I, Buzzigoli L, Tuscano G, Falduto M, Rippa V, Ashhab Y, Bensi G, Fontana MR, Seib KL, Mobley HL, Pizza M, Soriani M, Serino L.

PLoS Pathog. 2014 May 8;10(5):e1004124. doi: 10.1371/journal.ppat.1004124. eCollection 2014 May. Erratum in: PLoS Pathog. 2015 Mar;11(3):e1004773.


Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells.

Alteri CJ, Himpsl SD, Pickens SR, Lindner JR, Zora JS, Miller JE, Arno PD, Straight SW, Mobley HL.

PLoS Pathog. 2013;9(9):e1003608. doi: 10.1371/journal.ppat.1003608. Epub 2013 Sep 5.


The multifunctional protein YdiV represses P fimbria-mediated adherence in uropathogenic Escherichia coli.

Spurbeck RR, Alteri CJ, Himpsl SD, Mobley HL.

J Bacteriol. 2013 Jul;195(14):3156-64. doi: 10.1128/JB.02254-12. Epub 2013 May 10.


Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model.

Tyler JS, Beeri K, Reynolds JL, Alteri CJ, Skinner KG, Friedman JH, Eaton KA, Friedman DI.

PLoS Pathog. 2013 Mar;9(3):e1003236. doi: 10.1371/journal.ppat.1003236. Epub 2013 Mar 28.


Anaerobic respiration using a complete oxidative TCA cycle drives multicellular swarming in Proteus mirabilis.

Alteri CJ, Himpsl SD, Engstrom MD, Mobley HL.

MBio. 2012 Oct 30;3(6). pii: e00365-12. doi: 10.1128/mBio.00365-12.


Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments.

Alteri CJ, Mobley HL.

Curr Opin Microbiol. 2012 Feb;15(1):3-9. doi: 10.1016/j.mib.2011.12.004. Epub 2011 Dec 27. Review.


The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli.

Alteri CJ, Lindner JR, Reiss DJ, Smith SN, Mobley HL.

Mol Microbiol. 2011 Oct;82(1):145-63. doi: 10.1111/j.1365-2958.2011.07804.x. Epub 2011 Sep 2.


Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Vigil PD, Alteri CJ, Mobley HL.

Infect Immun. 2011 Jun;79(6):2335-44. doi: 10.1128/IAI.00110-11. Epub 2011 Mar 21.


Mucosal immunization with iron receptor antigens protects against urinary tract infection.

Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HL.

PLoS Pathog. 2009 Sep;5(9):e1000586. doi: 10.1371/journal.ppat.1000586. Epub 2009 Sep 18.


Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle.

Alteri CJ, Smith SN, Mobley HL.

PLoS Pathog. 2009 May;5(5):e1000448. doi: 10.1371/journal.ppat.1000448. Epub 2009 May 29.


Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract.

Lane MC, Alteri CJ, Smith SN, Mobley HL.

Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16669-74. Epub 2007 Oct 9.


Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine.

Alteri CJ, Mobley HL.

Infect Immun. 2007 Jun;75(6):2679-88. Erratum in: Infect Immun. 2009 Mar;77(3):1272.


Mycobacterium tuberculosis produces pili during human infection.

Alteri CJ, Xicohténcatl-Cortes J, Hess S, Caballero-Olín G, Girón JA, Friedman RL.

Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5145-50. Epub 2007 Mar 8.

Supplemental Content

Loading ...
Support Center